| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/04/2009 | US7569351 P53 dependent apoptosis-associated gene and protein |
| 08/04/2009 | US7569227 Monomeric protein of the TGF-β family |
| 08/04/2009 | US7569221 Compositions and methods for identifying agents that alter expression of survivin |
| 08/04/2009 | US7569220 Eukaryotic cell overexpressing an endogenous gene; introducing a vector containing a transcriptional regulatory sequence into the cell, allowing the vector to integrate into the genome of the cell by non-homologous recombination |
| 08/04/2009 | US7569219 Delivery of recombinant dsRNA phage to eukaryotic cells and tissues, either by direct administration, formulated in lipid or lactide-glycolide copolymer, or by utilizing a bacterial vaccine vector |
| 08/04/2009 | US7569218 Compositions for and methods of using herpes simplex virus glycoprotein D to suppress immune responses |
| 08/04/2009 | US7569217 Porcine adenovirus E1 and E4 regions |
| 08/01/2009 | CA2617487A1 Algorithm to manage gene network to |
| 07/30/2009 | WO2009093447A1 Anti-tumor agent for gastrointestinal cancer |
| 07/30/2009 | WO2009093188A2 Sequence specific double-stranded dna binding compounds |
| 07/30/2009 | WO2009092323A1 Uses of pdcd5 polypeptide for tumor chemotherapy and organ protection |
| 07/30/2009 | WO2009092133A1 Methods for identifying compounds capable of treating or preventing a diabetic complication via set7 or suv39 methyltransferases |
| 07/30/2009 | WO2009062169A8 Micro-rnas of the mir-15 family modulate cardiomyocyte survival and cardiac repair |
| 07/30/2009 | WO2009027349A3 Treatment and prevention of neurodegenerative diseases |
| 07/30/2009 | WO2008116032A8 Compositions and methods for inhibiting tumor cell growth |
| 07/30/2009 | WO2008094516A8 Multi-targeting short interfering rnas |
| 07/30/2009 | WO2007092944A8 Compositions and methods involving gene therapy and proteasome modulation |
| 07/30/2009 | US20090192114 miR-10 Regulated Genes and Pathways as Targets for Therapeutic Intervention |
| 07/30/2009 | US20090192113 Interfering RNA Duplex Having Blunt-Ends and 3`-Modifications |
| 07/30/2009 | US20090192109 Compositions for diagnosis and therapy of diseases associated with aberrant expression of Kremen and/or Wnt |
| 07/30/2009 | US20090192105 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA) |
| 07/30/2009 | US20090192088 Vascular Endothelial Growth Factor 2 |
| 07/30/2009 | US20090192082 Cxcr4 antagonist treatment of hematopoietic cells |
| 07/30/2009 | US20090191650 Diagnosing alzheimer's disease via presence of variant brain membrane protein |
| 07/30/2009 | US20090191572 Imaging, diagnosis and treatment of disease |
| 07/30/2009 | US20090191261 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 07/30/2009 | US20090191241 Method and compositions for immunization with the pseudomonas v antigen |
| 07/30/2009 | US20090191210 Method for inhibiting tumor invasion or spreading in a subject |
| 07/30/2009 | US20090191188 Immunostimulatory nucleic acids |
| 07/30/2009 | US20090191172 Method of Controlling Administration of Cancer Antigen |
| 07/30/2009 | US20090191170 Nucleic acid compositions and methods of introducing nucleic acids into cells |
| 07/30/2009 | US20090191166 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
| 07/30/2009 | US20090191146 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 07/29/2009 | EP2083272A1 Cancer cell identification marker and cancer cell proliferation inhibitor |
| 07/29/2009 | EP2081649A2 Modulation of cd1b or cd1d expression in autoimmune disorders |
| 07/29/2009 | EP1432441B1 Use of hmgb1 for the activation of dendritic cells |
| 07/29/2009 | EP1389043B1 Foot and mouth disease virus vaccine |
| 07/29/2009 | EP1347805B1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/29/2009 | EP1292676B1 Mutation associated with epilepsy |
| 07/29/2009 | EP1002110B2 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 07/29/2009 | EP0879284B1 Gene expression vectors which generate an antigen specific immune response and methods of using the same |
| 07/29/2009 | CN101495157A Disease treating method |
| 07/29/2009 | CN101495156A Pathotropic targeted gene delivery system for cancer and other disorders |
| 07/29/2009 | CN101491683A Development of new-generation gene-therapy immuno-therapy for alzheimer's disease |
| 07/29/2009 | CN101491670A Method for treating cardiovascular disease using nervous regulation protein and composite |
| 07/29/2009 | CN101491536A Therapeutically useful synthetic oligonucleotides |
| 07/29/2009 | CN100520408C Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 07/29/2009 | CN100519749C Agonist anti-TRK-C monoclonal antibodies |
| 07/28/2009 | US7566769 Pure polypeptide containing a fragment capable of binding to and inducing apoptosis in a carcinoma cell; Tumor Necrosis Factor Related ligand "TRELL; gene therapy to treat tumors, autoimmune and inflammatory diseases or inherited genetic disorders |
| 07/28/2009 | US7566766 Use of phage display libraries in a screening assay in order to determine the identity of peptides sequences which enhance the delivery of the bacteriophage through tissue, such as epithelial cells lining the lumen of gastrointestinal tract |
| 07/28/2009 | US7566764 Truncated BARD1 protein, and its diagnostic and therapeutic uses |
| 07/28/2009 | US7566695 Multimeric apoprotein agonists |
| 07/28/2009 | US7566566 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
| 07/28/2009 | US7566559 Human cyclin-dependent kinase (hPNQALRE) |
| 07/28/2009 | US7566555 Expressing in isolated animal cells a mutant tyrosyl-tRNA synthetase, Bacillus stearothermophilus suppressor tyrosyl tRNA, a gene encoding a desired protein comprising a nonsense mutation at a desired site |
| 07/28/2009 | US7566552 Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 07/28/2009 | US7566535 Enhanced oligonucleotide-mediated nucleic acid sequence alteration |
| 07/28/2009 | US7566446 Wound healing and treatment of fibrosis |
| 07/23/2009 | WO2009091904A2 Microrna based methods and compositions for the treatment of cancer |
| 07/23/2009 | WO2009091815A2 Methods for modulating de novo hepatic lipogenesis by modulating xbp-1 activity |
| 07/23/2009 | WO2009090639A2 Sirna compounds and methods of use thereof |
| 07/23/2009 | WO2009090330A2 Use of protein 8c2 for in vitro diagnosis of mycoplasma pneumoniae infections |
| 07/23/2009 | WO2009056965A3 A multicomponent or monocomponent vaccine to be used against chagas disease |
| 07/23/2009 | WO2009046395A3 Method to predict response to treatment for psychiatric illnesses |
| 07/23/2009 | WO2009045536A3 Receptor targeted oligonucleotides |
| 07/23/2009 | WO2008046943A8 Transposon hsmar2 and use thereof in the generation of vectors that can be used in somatic gene therapy |
| 07/23/2009 | WO2006110240A3 Gene transfer with adenoviruses having modified fiber proteins |
| 07/23/2009 | WO2005056752A9 Methods and compositions for delivering polynucleotides |
| 07/23/2009 | US20090186846 Methods to reprogram splice site selection in pre-messenger RNAs |
| 07/23/2009 | US20090186844 SiRNA DELIVERY INTO MAMMALIAN NERVE CELLS |
| 07/23/2009 | US20090186843 RNA sequence-specific mediators of RNA interference |
| 07/23/2009 | US20090186842 Methods and compositions for inhibition of viral replication |
| 07/23/2009 | US20090186338 Oligonucleotides originating from sequences coding for the surface component of ptlv envelope proteins and their uses |
| 07/23/2009 | US20090186010 Methods for the identification of ikkalfa function and other genes useful for treatment of inflammatory diseases |
| 07/23/2009 | US20090186008 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/23/2009 | US20090186003 Herpes simplex virus expressing foreign genes and method for treating cancers therewith |
| 07/23/2009 | US20090186002 rAAV-delivered alpha-1-antitrypsin compositions and method for the treatment and prevention of diabetes |
| 07/23/2009 | US20090185979 Integrin Heterodimer and an Alpha Subunit Thereof |
| 07/23/2009 | DE102007056488A1 Composition, useful e.g. transfection comprises a non-viral gene delivery system containing e.g. cationic lipid, and an agent for partial suppression and/or activation of innate intracellular and/or intercellular immune defense |
| 07/22/2009 | EP2080804A1 Modified cytokines for use in cancer therapy |
| 07/22/2009 | EP2080767A1 Composition for introduction of nucleic acid |
| 07/22/2009 | EP2080520A1 Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiogenesis |
| 07/22/2009 | EP2079517A2 Electronic and biological pacemaker systems |
| 07/22/2009 | EP2006377A9 Novel tumor antigen peptides |
| 07/22/2009 | EP2006293A9 2'-hydroxyl-modified ribonucleoside derivative |
| 07/22/2009 | EP1432791B1 Alphavirus replicon vector systems |
| 07/22/2009 | EP1395293B1 Lentiviral vectors encoding clotting factors for gene therapy |
| 07/22/2009 | EP1280900B1 Dendritic cell co-stimulatory molecules |
| 07/22/2009 | EP1231840B1 Anti-angiogenic cellular agent for cancer therapy |
| 07/22/2009 | EP1220922B1 Method of identifying a compound with efficacy in the treatment of chronic inflammatory diseases |
| 07/22/2009 | EP1133517B1 INTRANUCLEAR TARGETED DELIVERY OF COMPOUNDS BY 70 kD HEAT SHOCK PROTEIN |
| 07/22/2009 | EP1075283B1 A process of delivering a polynucleotide to a cell via the vascular system |
| 07/22/2009 | EP1027033B1 High efficiency encapsulation of nucleic acids in lipid vesicles |
| 07/22/2009 | CN101489593A Tumor-specific delivery of therapeutic agents via liposomase |
| 07/22/2009 | CN101485888A Anti-tumor DNA vaccine and preparation method thereof |
| 07/22/2009 | CN100515494C Immunisation against chlamydia trachomatis |
| 07/21/2009 | US7563884 Antisense modulation of PTP1B expression |
| 07/21/2009 | US7563862 Neural regeneration peptides and methods for their use in treatment of brain damage |
| 07/21/2009 | US7563778 Antisense oligonucleotide preparation method |
| 07/21/2009 | US7563777 Method to induce neovascular formation and tissue regeneration |